IP Library Granted Patent US 8,986,972
Granted Patent B2
US 8,986,972 · App. 14/466,939 · Granted Mar 24, 2015

Nucleic acid encoding DLL3 antibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,986,972
App. No.
14/466,939
Granted
Mar 24, 2015
Kind
B2
Abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Claims (30)

1. A nucleic acid encoding a polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 212.

2. The nucleic acid of claim 1 comprising the nucleotide sequence of SEQ ID NO: 412.

3. A nucleic acid encoding a polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 213.

4. The nucleic acid of claim 3 comprising the nucleotide sequence of SEQ ID NO: 413.

5. A vector comprising at least one of (a) a nucleic acid encoding a polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 212, and (b) a nucleic acid encoding a polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 213.

6. The vector of claim 5 , further comprising a promoter that controls expression of the nucleic acid of (a) or the nucleic acid of (b).

7. The vector of claim 5 comprising the nucleic acid of (a) and the nucleic acid of (b).

8. The vector of claim 7 , further comprising a promoter that controls expression of the nucleic acid of (a) and the nucleic acid of (b).

9. The vector of claim 7 , further comprising a first promoter that controls expression of the nucleic acid of (a) and a second promoter that controls expression of the nucleic acid of (b).

10. The vector of claim 5 , wherein the at least one nucleic acid comprises a nucleotide sequence set forth as SEQ ID NO: 412.

11. The vector of claim 5 , wherein the at least one nucleic acid comprises a nucleotide sequence set forth as SEQ ID NO: 413.

12. A host cell comprising at least one of (a) a nucleic acid encoding a polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 212, and (b) a nucleic acid encoding a polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 213.

13. The host cell of claim 12 , which is a mammalian host cell selected from the group consisting of CHO cell, HEK 293 cell, BHK cell, NSO cell, SP2/0 cell, YO myeloma cell, P3X63 mouse myeloma cell, PER cell, and PER.C6 cell.

14. The host cell of claim 13 , which is a CHO cell.

15. The host cell of claim 12 comprising the nucleic acid of (a) and the nucleic acid of (b).

16. The host cell of claim 12 , further comprising a vector comprising the nucleic acid of (a) or the nucleic acid of (b).

17. The host cell of claim 16 , wherein the vector comprises a promoter that controls expression of the nucleic acid of (a) or the nucleic acid of (b).

18. The host cell of claim 12 , further comprising a vector comprising the nucleic acid of (a) and the nucleic acid of (b).

19. The host cell of claim 18 , wherein the vector comprises a promoter that controls expression of the nucleic acid of (a) and the nucleic acid of (b).

20. The host cell of claim 18 , wherein the vector comprises a first promoter that controls expression of the nucleic acid of (a) and a second promoter that controls expression of the nucleic acid of (b).

21. The host cell of claim 12 , wherein the host cell expresses the polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 212.

22. The host cell of claim 21 , which is a CHO cell.

23. The host cell of claim 12 , wherein the host cell expresses the polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 213.

24. The host cell of claim 23 , which is a CHO cell.

25. The host cell of claim 12 , wherein the host cell expresses the polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 212 and the polypeptide comprising the amino acid sequence set forth as SEQ ID NO: 213.

26. The host cell of claim 25 , which is a CHO cell.

27. The host cell of claim 12 , wherein the host cell expresses an antibody comprising a light chain variable region comprising an amino acid sequence set forth as SEQ ID NO: 212.

28. The host cell of claim 12 , wherein the host cell expresses an antibody comprising a heavy chain variable region comprising an amino acid sequence set forth as SEQ ID NO: 213.

29. The host cell of claim 12 , wherein the host cell expresses an antibody comprising a light chain variable region comprising an amino acid sequence set forth as SEQ ID NO: 212 and a heavy chain variable region comprising an amino acid sequence set forth as SEQ ID NO: 213.

30. The host cell of claim 29 , which is a CHO cell.

Assignments (3)
MERGER Recorded Aug 7, 2016
From: STEMCENTRX, INC.
To: ABBVIE STEMCENTRX LLC
Reel/Frame 039601/0189 →
CHANGE OF NAME Recorded Mar 19, 2015
From: STEM CENTRX, INC.
To: STEMCENTRX, INC.
Reel/Frame 035226/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2014
From: STULL, ROBERT A.; SAUNDERS, LAURA; DYLLA, SCOTT J.; FOORD, ORIT; LIU, DAVID; TORGOV, MICHAEL; SHAO, HUI
To: STEM CENTRX, INC.
Reel/Frame 033717/0039 →